Home LiteratureArticle Details
PMID: 19495422 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Mural cell associated VEGF is required for organotypic vessel formation.

PloS one ·Vol. 4 ·No. 6 ·2009-06-04 ·Pages e5798

Evensen L, Micklem DR, Blois A, Berge SV, Aarsaether N, Littlewood-Evans A, Wood J, Lorens JB

Abstract

Blood vessels comprise endothelial cells, mural cells (pericytes/vascular smooth muscle cells) and basement membrane. During angiogenesis, mural cells are recruited to sprouting endothelial cells and define a stabilizing context, comprising cell-cell contacts, secreted growth factors and extracellular matrix components, that drives vessel maturation and resistance to anti-angiogenic therapeutics. To better understand the basis for mural cell regulation of angiogenesis, we conducted high content imaging analysis on a microtiter plate format in vitro organotypic blood vessel system comprising primary human endothelial cells co-cultured with primary human mural cells. We show that endothelial cells co-cultured with mural cells undergo an extensive series of phenotypic changes reflective of several facets of blood vessel formation and maturation: Loss of cell proliferation, pathfinding-like cell migration, branching morphogenesis, basement membrane extracellular matrix protein deposition, lumen formation, anastamosis and development of a stabilized capillary-like network. This phenotypic sequence required endothelial-mural cell-cell contact, mural cell-derived VEGF and endothelial VEGFR2 signaling. Inhibiting formation of adherens junctions or basement membrane structures abrogated network formation. Notably, inhibition of mural cell VEGF expression could not be rescued by exogenous VEGF. These results suggest a unique role for mural cell-associated VEGF in driving vessel formation and maturation.

MeSH Terms
Adherens Junctions/metabolism Angiogenesis Inhibitors/pharmacology Basement Membrane/metabolism Blood Vessels/pathology Capillaries/metabolism Cell Communication Cell Proliferation Coculture Techniques Endothelial Cells/metabolism Extracellular Matrix/metabolism Humans Intercellular Signaling Peptides and Proteins/metabolism Neovascularization, Physiologic RNA Interference Vascular Endothelial Growth Factor A/metabolism
Chemicals
Angiogenesis Inhibitors Intercellular Signaling Peptides and Proteins Vascular Endothelial Growth Factor A
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Evensen Lasse
Department of Biomedicine, University of Bergen, Bergen, Norway.
Micklem David R
Blois Anna
Berge Sissel Vik
Aarsaether Niels
Littlewood-Evans Amanda
Wood Jeanette
Lorens James B
References (42)
42 references, click to expand
  1. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis.
    Circ Res. 2008 Mar 28;102(6):637-52 PMID: 18369162
  2. Signaling vascular morphogenesis and maintenance.
    Science. 1997 Jul 4;277(5322):48-50 PMID: 9229772
  3. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
    Science. 1997 Jul 4;277(5322):55-60 PMID: 9204896
  4. VEGF receptor signalling - in control of vascular function.
    Nat Rev Mol Cell Biol. 2006 May;7(5):359-71 PMID: 16633338
  5. Multiple roles for the receptor tyrosine kinase axl in tumor formation.
    Cancer Res. 2005 Oct 15;65(20):9294-303 PMID: 16230391
  6. Pericyte isolation and use in endothelial/pericyte coculture models.
    Methods Enzymol. 2008;443:315-31 PMID: 18772023
  7. Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival.
    Dev Biol. 2003 Dec 1;264(1):275-88 PMID: 14623248
  8. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells.
    J Cell Biol. 1987 Sep;105(3):1455-62 PMID: 3654761
  9. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Lab Invest. 1993 Nov;69(5):508-17 PMID: 8246443
  10. Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis.
    Lab Invest. 2006 Nov;86(11):1172-84 PMID: 16969369
  11. Differential gene expression in a coculture model of angiogenesis reveals modulation of select pathways and a role for Notch signaling.
    Physiol Genomics. 2009 Jan 8;36(2):69-78 PMID: 18984672
  12. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness.
    FASEB J. 2001 Feb;15(2):447-57 PMID: 11156960
  13. Antiangiogenic therapy for cancer: current and emerging concepts.
    Oncology (Williston Park). 2005 Apr;19(4 Suppl 3):7-16 PMID: 15934498
  14. Role of laminin terminal globular domains in basement membrane assembly.
    J Biol Chem. 2007 Jul 20;282(29):21437-47 PMID: 17517882
  15. Endothelial cell-cell junctions: happy together.
    Nat Rev Mol Cell Biol. 2004 Apr;5(4):261-70 PMID: 15071551
  16. What tangled webs they weave: Rho-GTPase control of angiogenesis.
    Cell Mol Life Sci. 2007 Aug;64(16):2053-65 PMID: 17530172
  17. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
    Nature. 2008 Dec 11;456(7223):809-13 PMID: 18997771
  18. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Cancer Res. 2000 Apr 15;60(8):2178-89 PMID: 10786682
  19. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo.
    Angiogenesis. 2001;4(2):113-21 PMID: 11806243
  20. Modes of resistance to anti-angiogenic therapy.
    Nat Rev Cancer. 2008 Aug;8(8):592-603 PMID: 18650835
  21. Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation.
    Stem Cells Dev. 2004 Oct;13(5):509-20 PMID: 15588508
  22. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.
    J Cell Biol. 2001 Apr 30;153(3):543-53 PMID: 11331305
  23. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.
    J Clin Invest. 2004 Feb;113(4):516-27 PMID: 14966561
  24. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.
    Proc Natl Acad Sci U S A. 1989 Jun;86(12):4544-8 PMID: 2734305
  25. Tightening of endothelial cell contacts: a physiologic response to cocultures with smooth-muscle-like 10T1/2 cells.
    J Invest Dermatol. 2002 Jul;119(1):143-53 PMID: 12164937
  26. Stable, stoichiometric delivery of diverse protein functions.
    J Biochem Biophys Methods. 2004 Feb 27;58(2):101-10 PMID: 14980783
  27. Retroviral delivery of peptide modulators of cellular functions.
    Mol Ther. 2000 May;1(5 Pt 1):438-47 PMID: 10933965
  28. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization.
    Circ Res. 2005 Nov 25;97(11):1093-107 PMID: 16306453
  29. Rac regulates endothelial morphogenesis and capillary assembly.
    Mol Biol Cell. 2002 Jul;13(7):2474-85 PMID: 12134084
  30. NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1.
    Circ Res. 2009 Feb 27;104(4):466-75 PMID: 19150886
  31. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors.
    Cancer Res. 2004 Jun 1;64(11):3731-6 PMID: 15172975
  32. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.
    J Clin Invest. 2002 Dec;110(11):1619-28 PMID: 12464667
  33. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.
    Nat Biotechnol. 2004 Dec;22(12):1567-72 PMID: 15558047
  34. Cellular abnormalities of blood vessels as targets in cancer.
    Curr Opin Genet Dev. 2005 Feb;15(1):102-11 PMID: 15661540
  35. The role of pericytes in blood-vessel formation and maintenance.
    Neuro Oncol. 2005 Oct;7(4):452-64 PMID: 16212810
  36. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
    Toxicol Pathol. 2006;34(6):763-75 PMID: 17162534
  37. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
    Cancer Res. 1997 Oct 15;57(20):4593-9 PMID: 9377574
  38. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy.
    Am J Pathol. 2004 Apr;164(4):1263-73 PMID: 15039215
  39. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.
    Nat Cell Biol. 2005 Sep;7(9):870-9 PMID: 16113679
  40. Molecular regulation of angiogenesis and lymphangiogenesis.
    Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78 PMID: 17522591
  41. Molecular regulation of vessel maturation.
    Nat Med. 2003 Jun;9(6):685-93 PMID: 12778167
  42. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.
    J Clin Invest. 1999 Jan;103(2):159-65 PMID: 9916127
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2009-06-04
Epub
2009-00-04
Pages
e5798
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC2688382
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com